CD63 and neoplasm: The researchers knocked out MMP3 in tumor organoids, highlighting MMP3’s dual role in tumoroid structure and EV integrity, showing that MMP3-rich EVs rescue proliferation and CD9/CD63 expression in deficient organoids, thereby positioning MMP3 as a key modulator of tumor EV function [203].